100 related articles for article (PubMed ID: 6172177)
1. The role of abdominal surgery in the treatment of advanced testicular germ cell tumours.
Jones BM; Newlands ES; Begent RH; Rustin GJ; Bagshawe KD; Johnson AG; Reynolds KW
Br J Surg; 1982 Jan; 69(1):4-6. PubMed ID: 6172177
[TBL] [Abstract][Full Text] [Related]
2. Tumour markers in testicular germ cell tumours. Five-year experience from the DATECA Study 1976-1980.
Nørgaard-Pedersen B; Schultz HP; Arends J; Brincker H; Krag Jacobsen G; Lindeløv B; Rørth M; Svennekjaer IL
Acta Radiol Oncol; 1984; 23(4):287-94. PubMed ID: 6208749
[TBL] [Abstract][Full Text] [Related]
3. Surgery in the management of stage III germinal cell tumors. Observations on the M.D. Anderson Hospital experience, 1971-1979.
Logothetis CJ; Samuels ML
Cancer Treat Rev; 1984 Mar; 11(1):27-37. PubMed ID: 6203643
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and therapy of malignant testicular neoplasms].
Douwes FR; Yu D; Truss F
Onkologie; 1978 Oct; 1(5):185-92. PubMed ID: 83558
[TBL] [Abstract][Full Text] [Related]
5. Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors.
Peckham MJ; Barrett A; McElwain TJ; Hendry WF; Raghavan D
Br J Urol; 1981 Apr; 53(2):162-72. PubMed ID: 6165424
[TBL] [Abstract][Full Text] [Related]
6. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
Fosså SD; Aass N; Ous S; Høie J; Stenwig AE; Lien HH; Paus E; Kaalhus O
J Urol; 1989 Nov; 142(5):1239-42. PubMed ID: 2478726
[TBL] [Abstract][Full Text] [Related]
7. Testicular tumour markers in tissue correlated to serum levels and clinical stage.
Alm P; Hultberg B; Olsson AM
Scand J Urol Nephrol; 1984; 18(4):283-8. PubMed ID: 6209794
[TBL] [Abstract][Full Text] [Related]
8. Postoperative reduction of serum beta-HCG in testicular seminoma.
Sakashita S; Demura T; Gotoh T; Maru A; Koyanagi T
Int Urol Nephrol; 1988; 20(3):281-6. PubMed ID: 2456999
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing the survival of patients with testicular teratoma.
Alderdice JM; Merrett JD
J Clin Pathol; 1985 Jul; 38(7):791-6. PubMed ID: 2410461
[TBL] [Abstract][Full Text] [Related]
10. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
[TBL] [Abstract][Full Text] [Related]
11. Cytoreductive surgery in disseminated non-seminomatous germ cell tumours of testis.
Kulkarni RP; Reynolds KW; Newlands ES; Dawson PM; Makey AR; Theodorou NA; Bradley J; Begent RH; Rustin GJ; Bagshawe KD
Br J Surg; 1991 Feb; 78(2):226-9. PubMed ID: 1707715
[TBL] [Abstract][Full Text] [Related]
12. Biochemical markers for testicular germ-cell tumors in relation to histology and stage: some experiences from the Danish testicular cancer (DATECA) Study from 1976 through 1981.
Nørgaard-Pedersen B; Schultz H; Arends J; Brincker H; Jacobsen GK; Lindeløv B; Rørth M; Svennekjaer IL
Ann N Y Acad Sci; 1983; 417():390-9. PubMed ID: 6200044
[TBL] [Abstract][Full Text] [Related]
13. Tumour-marker levels and prognosis in malignant teratoma of the testis.
Germa-Lluch JR; Begent RH; Bagshawe KD
Br J Cancer; 1980 Dec; 42(6):850-5. PubMed ID: 6161630
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.
Stevens MJ; Norman AR; Dearnaley DP; Horwich A
J Clin Oncol; 1995 Jan; 13(1):87-92. PubMed ID: 7528272
[TBL] [Abstract][Full Text] [Related]
15. The changing role of surgery in metastatic non-seminomatous germ cell tumour.
Cassidy J; Lewis CR; Kaye SB; Kirk D
Br J Cancer; 1992 Jan; 65(1):127-9. PubMed ID: 1370759
[TBL] [Abstract][Full Text] [Related]
16. Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period.
Tröbs RB; Krauss M; Geyer C; Tannapfel A; Körholz D; Hirsch W
Klin Padiatr; 2007; 219(3):146-51. PubMed ID: 17525908
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in metastatic nonseminomatous germ cell tumours.
Hanson PR; Belitsky P; Millard OH; Lannon SG
Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
[TBL] [Abstract][Full Text] [Related]
18. Experience with serum alpha-fetoprotein and human chorionic gonadotropin in non-seminomatous testicular tumors.
Fowler JE; Taylor G; Blom J; Stutzman RE
J Urol; 1980 Sep; 124(3):365-8. PubMed ID: 6159485
[TBL] [Abstract][Full Text] [Related]
19. Does extragonadal presentation impart a worse prognosis to abdominal germ-cell tumours?
McAleer JJ; Nicholls J; Horwich A
Eur J Cancer; 1992; 28A(4-5):825-8. PubMed ID: 1381929
[TBL] [Abstract][Full Text] [Related]
20. [Biological markers for tumours of the testis. Their use in diagnosis, prognosis and follow-up in 200 cases (author's transl)].
Bellet D; Caillaud JM; Droz JP; Delarue JC; Bohuon C
Nouv Presse Med; 1981 Nov; 10(40):3293-7. PubMed ID: 6170931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
